A Study of Safety and Tolerability in Subjects With Schizophrenia

NCT01354353 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: LY2140023
DRUG: Aripiprazole

Sponsor

Denovo Biopharma LLC